# Exploratory Analysis of Factors Affecting 30-Day, 90-Day, and 1-Year Readmission After Surgical Treatment of Primary Spinal Infection in Adults

**Authors:** Ismail Ertan Sevin, Selin Bozdag, Onur Davut Dag, Ibrahim Eralp Sevin, Pelin Pugar, Tuna Demirdal, Hasan Kamil Sucu

PMC · DOI: 10.3390/jcm15041600 · Journal of Clinical Medicine · 2026-02-19

## TL;DR

This study explores factors linked to readmission after surgery for spinal infections but finds no significant associations due to limited data.

## Contribution

The study provides an exploratory analysis of readmission risk factors for spinal infection surgery in adults.

## Key findings

- Seventy-nine patients were analyzed, with 10.3% readmitted within one year.
- Staphylococcus aureus was the most common pathogen isolated.
- Liver disease, hypoalbuminemia, and postoperative transfusion showed trends toward higher readmission.

## Abstract

Background: Unplanned hospital readmission after surgical treatment of primary spinal infections (PSIs) represents a major clinical and economic burden. Despite the fact that advances in surgical and antimicrobial management have been made, risk stratification for early and late readmissions remains poorly defined. Objective: We aimed to explore the clinical, microbiological, and perioperative characteristics potentially associated with 30-day, 90-day, and 1-year unplanned readmissions following the surgical treatment of PSIs in adult patients. Methods: A retrospective cohort study was performed that included adult patients who underwent surgery for primary spinal infections between January 2017 and December 2023 at our tertiary referral center. Demographics, comorbidities, laboratory parameters, microbiological profiles, and postoperative outcomes were analyzed. Associations between candidate variables and readmission were explored using univariate statistical analyses; multivariable modeling was not performed due to the low number of readmission events. Results: In total, seventy-nine patients (mean age 62.2 ± 12.7 years; 38% female) were included. The in-hospital mortality rate was 5.1%; at 1-year follow-up, 10.3% of patients were readmitted and 5.9% required reoperation; and Staphylococcus aureus was the most common isolated pathogen. No independent variables demonstrated a statistically significant association with readmission. However, trends toward higher readmission were observed in patients with liver disease, hypoalbuminemia, and postoperative transfusion. Conclusions: In this exploratory single-center cohort, the low number of readmission events limited statistical power and precluded adjusted modeling. Univariate analyses did not identify statistically significant associations between the evaluated variables and 30-day, 90-day, or 1-year readmission; therefore, the results should be interpreted cautiously as hypothesis-generating. Larger prospective multicenter studies with adequate event counts are needed to support adjusted risk stratification approaches. Until such tools are available, close postoperative follow-up across all PSI patients is necessary.

## Linked entities

- **Diseases:** liver disease (MONDO:0005154)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** chronic systemic diseases (MESH:D002908), Infectious Diseases (MESH:D003141), tuberculous (MESH:D014390), chronic lung disease (MESH:D029424), osseous (MESH:C535395), vertebral osteomyelitis (MESH:D010019), Hypoalbuminemia (MESH:D034141), parasitic spinal infections (MESH:D010272), deformity (MESH:D009140), rod fracture (MESH:D017696), renal dysfunction (MESH:D007674), discitis (MESH:D015299), urinary tract infection (MESH:D014552), chronic kidney disease (MESH:D051436), rheumatologic disease (MESH:D012216), tuberculous disease (MESH:D014395), neuropsychiatric disorders (MESH:D001523), renal failure (MESH:D051437), cardiovascular disease (MESH:D002318), psoas abscesses (MESH:D016659), infection (MESH:D007239), chronic renal failure (MESH:D007676), bacteremia (MESH:D016470), lung disease (MESH:D008171), Diabetes (MESH:D003920), postoperative complications (MESH:D011183), malignancy (MESH:D009369), hypertension (MESH:D006973), pyogenic (MESH:D017789), soft-tissue infections (MESH:D018461), injury to (MESH:D014947), disease (MESH:D004194), abscess (MESH:D000038), inflammation (MESH:D007249), liver disease (MESH:D008107), echinococcosis (MESH:D004443)
- **Chemicals:** methicillin (MESH:D008712), Steroid (MESH:D013256)
- **Species:** Staphylococcus kloosii (species) [taxon 29384], Streptococcus suis (species) [taxon 1307], Serratia marcescens (species) [taxon 615], Streptococcus mitis (species) [taxon 28037], Micrococcus luteus (species) [taxon 1270], Klebsiella pneumoniae (species) [taxon 573], Staphylococcus epidermidis (species) [taxon 1282], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Mycobacterium tuberculosis (species) [taxon 1773], Pseudomonas aeruginosa (species) [taxon 287], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942489/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942489/full.md

---
Source: https://tomesphere.com/paper/PMC12942489